NO954414D0 - Transdermale terapeutiske systemer for administrering av serotonin-agonister - Google Patents
Transdermale terapeutiske systemer for administrering av serotonin-agonisterInfo
- Publication number
- NO954414D0 NO954414D0 NO954414A NO954414A NO954414D0 NO 954414 D0 NO954414 D0 NO 954414D0 NO 954414 A NO954414 A NO 954414A NO 954414 A NO954414 A NO 954414A NO 954414 D0 NO954414 D0 NO 954414D0
- Authority
- NO
- Norway
- Prior art keywords
- administration
- transdermal therapeutic
- therapeutic systems
- serotonin agonists
- active substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4314976A DE4314976C1 (de) | 1993-05-06 | 1993-05-06 | Transdermale therapeutische Systeme zur Verabreichung von Wirkstoffen, Verfahren zu ihrer Herstellung und ihre Verwendung |
PCT/EP1994/001280 WO1994026270A1 (fr) | 1993-05-06 | 1994-04-25 | Systemes therapeutiques transdermiques pour l'administration d'agonistes de la serotonine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO954414L NO954414L (no) | 1995-11-03 |
NO954414D0 true NO954414D0 (no) | 1995-11-03 |
Family
ID=6487316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO954414A NO954414D0 (no) | 1993-05-06 | 1995-11-03 | Transdermale terapeutiske systemer for administrering av serotonin-agonister |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP0697869B1 (fr) |
JP (1) | JPH08509749A (fr) |
KR (1) | KR960702306A (fr) |
AT (1) | ATE183392T1 (fr) |
AU (1) | AU686159B2 (fr) |
CA (1) | CA2160776A1 (fr) |
CZ (1) | CZ289395A3 (fr) |
DE (2) | DE4314976C1 (fr) |
DK (1) | DK0697869T3 (fr) |
ES (1) | ES2138659T3 (fr) |
FI (1) | FI955260A (fr) |
GR (1) | GR3031639T3 (fr) |
HU (1) | HUT74865A (fr) |
IL (1) | IL109509A (fr) |
NO (1) | NO954414D0 (fr) |
NZ (1) | NZ265949A (fr) |
PL (1) | PL179353B1 (fr) |
SK (1) | SK138095A3 (fr) |
WO (1) | WO1994026270A1 (fr) |
ZA (1) | ZA942872B (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10510540A (ja) | 1994-12-12 | 1998-10-13 | オメロス メディカル システムズ,インコーポレーテッド | 灌注用溶液並びに疼痛、炎症及びけいれんの抑制法 |
US8022095B2 (en) | 1996-08-16 | 2011-09-20 | Pozen, Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
AU753853B2 (en) * | 1999-12-14 | 2002-10-31 | Teikoku Seiyaku Co., Ltd | Drugs for relieving hemicrania |
US8329734B2 (en) | 2009-07-27 | 2012-12-11 | Afgin Pharma Llc | Topical therapy for migraine |
DK1435945T3 (da) * | 2001-06-05 | 2008-12-01 | Ronald Aung-Din | Topisk migræne terapi |
MXPA05006954A (es) | 2002-12-26 | 2005-09-22 | Pozen Inc | Formas de dosificacion de capas multiples que contienen nsaids y triptanos. |
US20070065463A1 (en) | 2003-06-20 | 2007-03-22 | Ronald Aung-Din | Topical therapy for the treatment of migranes, muscle sprains, muscle spasms, spasticity and related conditions |
BRPI0620216A2 (pt) * | 2005-12-20 | 2011-11-01 | Teikoku Pharma Usa Inc | métodos para administrar transdermicamente um agonista receptor de indol serotonina e composições transdérmicas para uso nos mesmos |
CN104138634B (zh) | 2006-04-13 | 2016-09-07 | 梯瓦制药国际有限责任公司 | 递送抗偏头痛化合物的透皮方法和系统 |
US8592424B2 (en) | 2008-06-30 | 2013-11-26 | Afgin Pharma Llc | Topical regional neuro-affective therapy |
CA2775404C (fr) | 2009-09-25 | 2017-01-03 | Dr. Reddy's Laboratories Limited | Formulations comprenant des composes triptan |
US11337962B2 (en) | 2009-09-25 | 2022-05-24 | Upsher-Smith Laboratories, Llc | Formulations comprising triptan compounds |
JP6216151B2 (ja) * | 2013-04-19 | 2017-10-18 | コスメディ製薬株式会社 | 親水性薬物のエマルジョンパッチ |
US20160256410A1 (en) | 2015-03-02 | 2016-09-08 | Afgin Pharma, Llc | Topical regional neuro-affective therapy in mammals with cannabinoids |
US10383816B2 (en) | 2015-03-02 | 2019-08-20 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with cannabinoid combination products |
US20180049994A1 (en) | 2016-08-16 | 2018-02-22 | Afgin Pharma, Llc | Topical regional neuro-affective therapy with caryophyllene |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3742951A (en) * | 1971-08-09 | 1973-07-03 | Alza Corp | Bandage for controlled release of vasodilators |
US3996934A (en) * | 1971-08-09 | 1976-12-14 | Alza Corporation | Medical bandage |
US5288498A (en) * | 1985-05-01 | 1994-02-22 | University Of Utah Research Foundation | Compositions of oral nondissolvable matrixes for transmucosal administration of medicaments |
GB2162522B (en) * | 1984-08-01 | 1988-02-24 | Glaxo Group Ltd | An indole derivative |
WO1992000103A1 (fr) * | 1990-06-28 | 1992-01-09 | Beecham Group Plc | Preparations pharmaceutiques |
GB9103770D0 (en) * | 1991-02-22 | 1991-04-10 | Glaxo Group Ltd | Chemical compounds |
GB9104890D0 (en) * | 1991-03-08 | 1991-04-24 | Glaxo Group Ltd | Compositions |
-
1993
- 1993-05-06 DE DE4314976A patent/DE4314976C1/de not_active Expired - Fee Related
-
1994
- 1994-04-25 PL PL94311591A patent/PL179353B1/pl unknown
- 1994-04-25 CZ CZ952893A patent/CZ289395A3/cs unknown
- 1994-04-25 AT AT94915109T patent/ATE183392T1/de active
- 1994-04-25 DE DE59408643T patent/DE59408643D1/de not_active Expired - Lifetime
- 1994-04-25 HU HU9503167A patent/HUT74865A/hu unknown
- 1994-04-25 CA CA002160776A patent/CA2160776A1/fr not_active Abandoned
- 1994-04-25 EP EP94915109A patent/EP0697869B1/fr not_active Expired - Lifetime
- 1994-04-25 DK DK94915109T patent/DK0697869T3/da active
- 1994-04-25 ES ES94915109T patent/ES2138659T3/es not_active Expired - Lifetime
- 1994-04-25 NZ NZ265949A patent/NZ265949A/en unknown
- 1994-04-25 AU AU66480/94A patent/AU686159B2/en not_active Ceased
- 1994-04-25 SK SK1380-95A patent/SK138095A3/sk unknown
- 1994-04-25 WO PCT/EP1994/001280 patent/WO1994026270A1/fr not_active Application Discontinuation
- 1994-04-25 JP JP6524861A patent/JPH08509749A/ja not_active Ceased
- 1994-04-26 ZA ZA942872A patent/ZA942872B/xx unknown
- 1994-05-02 IL IL10950994A patent/IL109509A/xx not_active IP Right Cessation
-
1995
- 1995-11-02 FI FI955260A patent/FI955260A/fi unknown
- 1995-11-03 NO NO954414A patent/NO954414D0/no not_active Application Discontinuation
- 1995-11-06 KR KR1019950705045A patent/KR960702306A/ko active IP Right Grant
-
1999
- 1999-10-27 GR GR990402728T patent/GR3031639T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
FI955260A0 (fi) | 1995-11-02 |
DK0697869T3 (da) | 2000-03-20 |
IL109509A (en) | 1999-12-22 |
NO954414L (no) | 1995-11-03 |
IL109509A0 (en) | 1994-08-26 |
AU6648094A (en) | 1994-12-12 |
DE4314976C1 (de) | 1994-10-06 |
FI955260A (fi) | 1995-11-17 |
CA2160776A1 (fr) | 1994-11-24 |
WO1994026270A1 (fr) | 1994-11-24 |
HU9503167D0 (en) | 1996-01-29 |
JPH08509749A (ja) | 1996-10-15 |
PL179353B1 (en) | 2000-08-31 |
NZ265949A (en) | 1997-10-24 |
ZA942872B (en) | 1995-07-06 |
AU686159B2 (en) | 1998-02-05 |
KR960702306A (ko) | 1996-04-27 |
HUT74865A (en) | 1997-02-28 |
GR3031639T3 (en) | 2000-02-29 |
PL311591A1 (en) | 1996-02-19 |
SK138095A3 (en) | 1996-06-05 |
DE59408643D1 (de) | 1999-09-23 |
ES2138659T3 (es) | 2000-01-16 |
EP0697869B1 (fr) | 1999-08-18 |
CZ289395A3 (en) | 1996-04-17 |
ATE183392T1 (de) | 1999-09-15 |
EP0697869A1 (fr) | 1996-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO954414L (no) | Transdermale terapeutiske systemer for administrering av serotonin-agonister | |
DE69527509D1 (de) | Hydrogelformulierung mit gesteuerter freisetzung | |
FI930862A0 (fi) | En doseringsform foer tidsvarierande moenster av laekemedeloeverlaotelse | |
NO911260L (no) | Utleveringssystem for aromastoff og soetningsmiddel, samt fremgangsmaate for fremstilling av et slikt system. | |
FI943280A0 (fi) | Osmoosiin perustuva laite ja lääkkeen annon viivytetty aktivointi sen avulla | |
AU4989997A (en) | Soluble form osmotic dose delivery system | |
MX9300014A (es) | Nuevos derivados de 1,2,4-triaminobenceno y procedimiento para su elaboracion. | |
MX9203422A (es) | Compuestos farmacologicamente activos para el sistema nervioso central. | |
NO943762L (no) | Indolderivater som 5-HT 1 agonister | |
NO305906B1 (no) | Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler | |
DK0825857T3 (da) | Anvendelse af gabapentin og derivater deraf til behandling af mani og bipolær lidelse | |
NO954287D0 (no) | Anvendelse av indolderivater som 5-HT1 agonister | |
DK1044064T3 (da) | Overtrækningsindretning til granula til indtagelse ad oral vej | |
NO306113B1 (no) | Adhesjonsreseptorantagonister, farmasöytiske preparater som inneholder slike forbindelser, samt anvendelse av forbindelsene til fremstilling av legemidler | |
ZA963743B (en) | Transdermal therapeutic system (TTS) for the administration of testosterone | |
CY1105463T1 (el) | Ελεγχομενη χορηγηση αντικαταθλιπτικων | |
MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
NO305836B1 (no) | Oksazolidin-2-on-forbindelser, farmas°ytiske preparater som inneholder minst Ún slik forbindelse, samt anvendelse av forbindelsene til fremstilling av legemidler | |
DE59608611D1 (de) | Topische aciclovir-zubereitung | |
DK0456792T3 (da) | Forbedret transdermalt system til indgivelse af farmakologisk aktive forbindelser under pH-kontrollerede betingelser | |
SI0697869T1 (en) | Transdermal therapeutic systems for the administration of serotonin agonists | |
NO931208L (no) | Formuleringer for transdermale kontraseptiver, samt fremgangsmaater og innretninger for tilfoersel av slike | |
DE69615340D1 (de) | Antimykotische zusammensetzung welche crotamiton und salicylaldehyd enthält | |
IT8820575A0 (it) | Apparecchio per la erogazione di sostanze nebulizzate. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |